MarketCap
Facebook
X
TelegramAnnual report 2022
added 10-07-2022
Allied Healthcare Products Operating Income 2011-2026 | AHPI
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Allied Healthcare Products
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.27 M | -1.13 M | 734 K | -2.77 M | -2 M | -2.05 M | -1.92 M | -1.69 M | -3.11 M | -2.49 M | -650 K | 409 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 734 K | -3.11 M | -1.49 M |
Quarterly Operating Income Allied Healthcare Products
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -1.23 M | -1.13 M | -952 K | -745 K | -381 K | 734 K | -135 K | 734 K | -305 K | -1.51 M | -607 K | -1.51 M | -607 K | -762 K | -1.23 M | -762 K | -1.23 M | -244 K | -767 K | -244 K | -767 K | -373 K | -817 K | -373 K | -817 K | -688 K | -635 K | -688 K | -635 K | -35 K | -698 K | -35 K | -698 K | -892 K | -862 K | -892 K | -862 K | -751 | -660 | -751 K | -660 K | 41 K | -228 K | 41 K | -228 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 734 K | -1.51 M | -565 K |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 7.25 | -8.17 % | $ 521 M |  Israel |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M |  USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-30.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.97 | - | $ 137 M | USA |
 |
Alphatec Holdings
ATEC
|
-136 M | $ 13.48 | -4.13 % | $ 1.93 B | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 4.08 | 0.37 % | $ 152 M |  France |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 299.07 | -2.23 % | $ 8.44 B | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 41.06 | -3.54 % | $ 6.12 K | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
2.6 B | $ 78.26 | 3.65 % | $ 115 B | USA |
 |
Abbott Laboratories
ABT
|
6.82 B | $ 109.11 | 0.84 % | $ 190 B | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 12.43 | -6.61 % | $ 336 M | USA |
 |
CONMED Corporation
CNMD
|
200 M | $ 40.63 | 1.75 % | $ 1.25 B | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 28.95 | -0.96 % | $ 245 M | USA |
 |
InMode Ltd.
INMD
|
113 M | $ 14.77 | -1.66 % | $ 1.17 B | Israel |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Profound Medical Corp.
PROF
|
-30.3 M | $ 6.35 | -6.89 % | $ 180 M | Canada |
 |
Align Technology
ALGN
|
608 M | $ 176.77 | 9.59 % | $ 13.2 B | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.54 | 0.11 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
166 M | $ 87.55 | 0.56 % | $ 11.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 10.94 | -1.26 % | $ 842 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-50 M | $ 66.7 | -3.52 % | $ 1.88 B |  Costa-rica |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.45 | 0.69 % | $ 23.4 M | USA |
 |
IRadimed Corporation
IRMD
|
22 M | $ 94.23 | 0.4 % | $ 1.19 B | USA |
 |
Integer Holdings Corporation
ITGR
|
208 M | $ 85.94 | 0.49 % | $ 2.89 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.67 | 0.3 % | $ 36.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-35 M | $ 16.64 | -1.54 % | $ 384 M | USA |